Cargando…
Crosstalk between m6A modification and alternative splicing during cancer progression
BACKGROUND: N6‐methyladenosine (m6A), the most prevalent internal mRNA modification in eukaryotes, is added by m6A methyltransferases, removed by m6A demethylases and recognised by m6A‐binding proteins. This modification significantly influences carious facets of RNA metabolism and plays a pivotal r...
Autores principales: | Zhu, Zhi‐Man, Huo, Fu‐Chun, Zhang, Jian, Shan, Hong‐Jian, Pei, Dong‐Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583157/ https://www.ncbi.nlm.nih.gov/pubmed/37850412 http://dx.doi.org/10.1002/ctm2.1460 |
Ejemplares similares
-
N(6)‐methyladenosine (m(6)A) RNA modification in human cancer
por: Huo, Fu‐Chun, et al.
Publicado: (2020) -
Function and evolution of RNA N6-methyladenosine modification
por: Zhu, Zhi-Man, et al.
Publicado: (2020) -
A crosstalk of circadian clock and alternative splicing under abiotic stresses in the plants
por: Fan, Tao, et al.
Publicado: (2022) -
Crosstalk between alternative splicing and inflammatory bowel disease: Basic mechanisms, biotechnological progresses and future perspectives
por: Zou, Chentao, et al.
Publicado: (2023) -
Alternative splicing of METTL3 explains apparently METTL3-independent m(6)A modifications in mRNA
por: Poh, Hui Xian, et al.
Publicado: (2022)